Furthermore, the fact that cells expressing E6 and E7 proteins from a low-oncogenic risk type are resistant to these cytokines support the notion that overcoming TNF and TRAIL cytostatic effect is needed at the very early stages of viral infection and it is not linked to cell immortalization or abrogation of p53 or pRb functions. The gene discussed is TNFSF10; the disease is viral infectious disease.